CN101535479A - 凝血酶突变体 - Google Patents
凝血酶突变体 Download PDFInfo
- Publication number
- CN101535479A CN101535479A CNA2007800423818A CN200780042381A CN101535479A CN 101535479 A CN101535479 A CN 101535479A CN A2007800423818 A CNA2007800423818 A CN A2007800423818A CN 200780042381 A CN200780042381 A CN 200780042381A CN 101535479 A CN101535479 A CN 101535479A
- Authority
- CN
- China
- Prior art keywords
- chain
- zymoplasm
- amino acid
- replaced
- serine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP309007/2006 | 2006-11-15 | ||
JP2006309007 | 2006-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101535479A true CN101535479A (zh) | 2009-09-16 |
Family
ID=39401721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800423818A Pending CN101535479A (zh) | 2006-11-15 | 2007-11-15 | 凝血酶突变体 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8088372B2 (zh) |
EP (2) | EP2399994A1 (zh) |
JP (1) | JPWO2008059917A1 (zh) |
KR (1) | KR20090081388A (zh) |
CN (1) | CN101535479A (zh) |
AU (1) | AU2007320353A1 (zh) |
BR (1) | BRPI0718633A2 (zh) |
CA (1) | CA2669641A1 (zh) |
RU (1) | RU2009122486A (zh) |
WO (1) | WO2008059917A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009086552A1 (en) * | 2008-01-02 | 2009-07-09 | The Trustees Of The University Of Pennsylvania | Targeting recombinant therapeutics to circulating red blood cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5688768A (en) | 1991-02-19 | 1997-11-18 | Cor Therapeutics, Inc. | Recombinant thrombin receptor and related pharmaceuticals |
US5256766A (en) | 1991-02-19 | 1993-10-26 | The Regents Of The University Of California | Recombinant thrombin receptor and related pharmaceuticals |
ATE293168T1 (de) | 1993-11-12 | 2005-04-15 | Gilead Sciences Inc | Thrombin mutanten |
AT404357B (de) | 1995-06-13 | 1998-11-25 | Immuno Ag | Prothrombin-derivate |
BRPI0508985A (pt) | 2004-03-19 | 2007-08-28 | Chisso Corp | derivado de trombina, dna, e, composição farmacêutica |
-
2007
- 2007-11-15 JP JP2008544191A patent/JPWO2008059917A1/ja not_active Withdrawn
- 2007-11-15 EP EP11176358A patent/EP2399994A1/en not_active Withdrawn
- 2007-11-15 WO PCT/JP2007/072169 patent/WO2008059917A1/ja active Application Filing
- 2007-11-15 AU AU2007320353A patent/AU2007320353A1/en not_active Abandoned
- 2007-11-15 US US12/514,735 patent/US8088372B2/en not_active Expired - Fee Related
- 2007-11-15 RU RU2009122486/10A patent/RU2009122486A/ru not_active Application Discontinuation
- 2007-11-15 KR KR1020097009875A patent/KR20090081388A/ko not_active Application Discontinuation
- 2007-11-15 CA CA002669641A patent/CA2669641A1/en not_active Abandoned
- 2007-11-15 BR BRPI0718633-9A2A patent/BRPI0718633A2/pt not_active IP Right Cessation
- 2007-11-15 EP EP07831899A patent/EP2093290A4/en not_active Withdrawn
- 2007-11-15 CN CNA2007800423818A patent/CN101535479A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
RU2009122486A (ru) | 2010-12-20 |
EP2399994A1 (en) | 2011-12-28 |
AU2007320353A1 (en) | 2008-05-22 |
BRPI0718633A2 (pt) | 2013-11-19 |
EP2093290A1 (en) | 2009-08-26 |
CA2669641A1 (en) | 2008-05-22 |
WO2008059917A1 (fr) | 2008-05-22 |
US20100040597A1 (en) | 2010-02-18 |
EP2093290A4 (en) | 2010-03-24 |
US8088372B2 (en) | 2012-01-03 |
KR20090081388A (ko) | 2009-07-28 |
JPWO2008059917A1 (ja) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5240913A (en) | Inhibitors of thrombin | |
JPH09509045A (ja) | トロンビン変異体 | |
Hovinga et al. | Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg 353--> Pro leading to loss of a kallikrein cleavage site | |
US6068838A (en) | Purified multimerase | |
AU2005222763B2 (en) | Thrombin derivatives and medicinal composition containing the same | |
JPH10509436A (ja) | 被阻害形態の被活性化血液因子の生成方法 | |
Phillips et al. | Thrombin-like snake venom serine proteinases | |
Wu et al. | The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex | |
CN101535479A (zh) | 凝血酶突变体 | |
Yang et al. | Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors | |
Mesters et al. | Interactions and inhibition of blood coagulation factor Va involving residues 311–325 of activated protein C | |
JPWO2008044631A1 (ja) | 播種性血管内血液凝固症候群の治療及び/又は改善剤 | |
US5510248A (en) | Stable recombinant meizothrombin-like polypeptides | |
Harlos et al. | Structure and order of the protein and carbohydrate domains of prothrombin fragment 1 | |
US7109170B2 (en) | Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor | |
RU2372402C2 (ru) | Производное тромбина и фармацевтическая композиция, содержащая его | |
Roddick et al. | Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | |
Côté | Studies of structure-function relationships in two human coagulation proteins: factor XII and prothrombin | |
Kim et al. | Platelet-agglutinating protein p37 from a patient with thrombotic thrombocytopenic purpura has characteristics similar to prethrombin 2 | |
GB2431655A (en) | Antagonisation of anticoagulants | |
Liaw | Interaction of thrombin with prothrombin fragment 2, heparin cofactor II, and fibrin. | |
Janska | B1. Proteases in pathophysiology | |
Geng | A mechanism for exosite-mediated factor IX activation by factor XIa | |
Huang | Mutational studies of factor X activation by tissue factor-factor VIIa | |
Siigur et al. | Polypeptides and proteins active in the coagulation process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JNC CORPORATION Free format text: FORMER OWNER: CHISSO CORPORATION Effective date: 20110915 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110915 Address after: Tokyo, Japan, Japan Applicant after: JNC Corporation Co-applicant after: Fujimori Kogyo Co., Ltd. Address before: Osaka Japan Applicant before: Chisso Corporation Co-applicant before: Fujimori Kogyo Co., Ltd. |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20090916 |